IL4 and asthma: The population of IL-4+ Th2 cells increased from 0.329% in PBS group to 0.736% in asthma group and 0.796% in severe asthma group, while recombinant Mycobacterium smegmatis vaccination significantly reduced IL-4+ Th2 cells in spleen.